Related Experiment Video

Updated: Jul 18, 2026

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

[The changes of general potential of hemocoagulation in children, suffering an acute hematogenic osteomyelitis]

A Iu Kazans'kyĭ, B M Bodnar

    Klinichna Khirurhiia
    |November 23, 2006
    PubMed

    Insights

    Children with acute hematogenic osteomyelitis exhibit secondary hypocoagulation due to soluble fibrin-monomer complexes. This condition, despite initial appearances, reflects an underlying hypercoagulation state in the blood

    Area of Science:

    • Hematology
    • Pediatric Medicine
    • Biochemistry

    Context:

    • Acute hematogenic osteomyelitis is a serious pediatric infection.
    • Coagulation disorders are frequently observed in patients with severe infections.
    • Understanding these disorders is crucial for effective treatment.

    Purpose:

    • To investigate the hemostatic balance in children with acute hematogenic osteomyelitis.
    • To elucidate the mechanisms behind observed coagulation abnormalities.
    • To determine the true coagulation status in these patients.

    Summary:

    • Children with acute hematogenic osteomyelitis display chronometric hypocoagulation.
    • This is characterized by prolonged coagulation times and altered fibrinogenesis.
    • Lowered anticoagulant capacity and increased platelet activity contribute to this state.
    • Accumulation of soluble fibrin-monomer complexes inhibits fibrinogenesis, masking an underlying hypercoagulable state.

    Impact:

    • Identifies soluble fibrin-monomer complexes as key mediators of hypocoagulation.
    • Reclassifies the overall coagulation potential in affected children as structural hypercoagulation.
    • Provides critical insights for managing coagulation disturbances in pediatric osteomyelitis.

    More Related Videos

    Microfluidics in Assessing Platelet Function06:47

    Microfluidics in Assessing Platelet Function

    Published on: November 8, 2024

    Related Concept Videos

    Introduction to Hemostasis01:05

    Introduction to Hemostasis

    Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
    The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
    Extrinsic and Intrinsic Pathways of Hemostasis01:20

    Extrinsic and Intrinsic Pathways of Hemostasis

    Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
    The Extrinsic Pathway
    The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
    Hemorrhagic Stroke ll: Pathophysiology01:29

    Hemorrhagic Stroke ll: Pathophysiology

    A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
    Overview of Hematopoiesis01:20

    Overview of Hematopoiesis

    Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
    Developmental Phases of Hematopoiesis
    Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
    Disorders of Hemostasis01:24

    Disorders of Hemostasis

    Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
    Thromboembolic Disorders
    Two factors primarily cause thromboembolic conditions.
    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...